Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma

医学 无容量 肝细胞癌 索拉非尼 瑞戈非尼 内科学 危险系数 肿瘤科 队列 胃肠病学 进行性疾病 安慰剂 疾病 免疫疗法 置信区间 癌症 结直肠癌 病理 替代医学
作者
Chang Gon Kim,Chan Kim,Sang Eun Yoon,Kyung Hwan Kim,Seong Jin Choi,Beodeul Kang,Hye Ryun Kim,Su‐Hyung Park,Eui‐Cheol Shin,Yeun‐Yoon Kim,Dae Jung Kim,Hyun Cheol Chung,Hong Jae Chon,Hye Jin Choi,Ho Yeong Lim
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:74 (2): 350-359 被引量:187
标识
DOI:10.1016/j.jhep.2020.08.010
摘要

Programmed cell death-1 (PD-1) inhibitor treatment can cause hyperprogressive disease (HPD), but the incidence, outcome, and predictive factors of HPD are unknown in patients with hepatocellular carcinoma (HCC). Herein, we assessed the existence and factors predictive of HPD in patients with advanced HCC treated with nivolumab.We enrolled 189 patients with advanced HCC treated with nivolumab. Occurrence of HPD was investigated using tumour growth dynamics based on tumour growth kinetics (TGK) and tumour growth rate (TGR) before and after treatment, or time to treatment failure. We additionally analysed patients treated with regorafenib (n = 95) or best supportive care (BSC)/placebo (n = 103) after progression on sorafenib to compare tumour growth dynamics.Flare-up of tumour growth was observed in a fraction of patients upon PD-1 blockade, indicating the occurrence of HPD. Based on distinct patterns of disease progression exclusively observed in the nivolumab-treated cohort, but not in the regorafenib- or BSC/placebo-treated cohorts, 4-fold increases in TGK and TGR ratios as well as a 40% increase in TGR were the cut-off values used to define HPD; 12.7% of the patients (24/189) treated with nivolumab met all these criteria. Patients with HPD had worse progression-free survival (hazard ratio [HR] 2.194; 95% CI 1.214-3.964) and overall survival (HR 2.238; 95% CI 1.233-4.062) compared to patients with progressive disease without HPD. More than 90% of patients with HPD missed the opportunity for subsequent treatment because of rapid clinical deterioration. An elevated neutrophil-to-lymphocyte ratio (>4.125) was associated with HPD and an inferior survival rate.HPD occurs in a fraction of patients with HCC who receive PD-1 inhibitor treatment. Analyses of the baseline immune profile and on-treatment tumour growth dynamics could enable optimal patient selection and earlier identification of HPD.Hyperprogressive disease is an unexpected response pattern observed in patients treated with an immune checkpoint inhibitor. This study revealed that hyperprogressive disease occurs in a fraction of patients with advanced hepatocellular carcinoma treated with an anti-PD-1 antibody, providing evidence to encourage careful monitoring of patients to prevent clinical deterioration induced by PD-1 blockade.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
beiheyu发布了新的文献求助10
刚刚
beiheyu发布了新的文献求助10
刚刚
beiheyu发布了新的文献求助30
1秒前
1秒前
LJW完成签到 ,获得积分10
1秒前
beiheyu发布了新的文献求助10
1秒前
Code_king发布了新的文献求助10
1秒前
奔跑的应助被parantal采纳,获得30
2秒前
coolplex完成签到,获得积分10
2秒前
我是老大的应助被lrq采纳,获得10
2秒前
2秒前
于yu发布了新的文献求助10
2秒前
academician完成签到,获得积分10
2秒前
小贺发布了新的文献求助30
3秒前
3秒前
beiheyu发布了新的文献求助10
4秒前
Ava的应助被小灰灰采纳,获得30
4秒前
爆米花的应助被外向梦山采纳,获得10
4秒前
beiheyu发布了新的文献求助10
4秒前
beiheyu发布了新的文献求助10
4秒前
杜杨帆发布了新的文献求助10
4秒前
5秒前
科研通AI65的应助被樱桃完犊子采纳,获得10
5秒前
5秒前
6秒前
6秒前
7秒前
李健的应助被Ghost_Hibiki采纳,获得10
7秒前
7秒前
自信谷冬发布了新的文献求助10
7秒前
8秒前
9秒前
无花果的应助被kiki采纳,获得10
9秒前
王一一发布了新的文献求助10
9秒前
10秒前
10秒前
彩色乐儿发布了新的文献求助10
10秒前
10秒前
123完成签到,获得积分10
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177464
求助须知:如何正确求助?哪些是违规求助? 9568344
关于积分的说明 21798806
捐赠科研通 7772101
什么是DOI,文献DOI怎么找? 3432346
关于科研通互助平台的介绍 2556593
邀请新用户注册赠送积分活动 2477882